Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
10 pending office actions • 9 art units • 9 examiners • 0 of 10 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Reckitt Benckiser Health Limited maintains a presence in the Biotechnology & Pharmaceuticals technology area, currently managing 10 pending office actions. These actions are distributed across 9 distinct art units. This distribution indicates that the company's patent strategy involves various specialized sub-fields within the biotechnology domain. The variety of art units involved implies that the company is pursuing applications of its core health technologies in different technical areas.
The prosecution workload involves 9 distinct examiners. ASDJODI, MOHAMMADREZA is the busiest examiner for this portfolio, currently overseeing 2 pending office actions. Practitioners must account for the interpretations and practices of 9 different examiners to ensure consistency across the portfolio. This level of examiner diversity necessitates a coordinated approach to claim construction across the various pending matters to maintain a unified intellectual property position.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (60%) |
| Double-patenting + other | 1 (10%) |
| Multi-statute (no §101) | 3 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ASDJODI, MOHAMMADREZA | 2 | 59.1% | +46.9% |
| MELENDEZ, ARMAND | 1 | 46.2% | +43.1% |
| ABBAS, ABDULRAHMAN MUSTAFA | 1 | 52.4% | +34.8% |
| GEMBEH, SHIRLEY V | 1 | 63.2% | +34.0% |
| SERGENT, RABON A | 1 | 55.0% | +24.1% |
| LEE, ANDREW P | 1 | 48.3% | +23.1% |
| LEE, MICHELLE J | 1 | 39.8% | +60.2% |
| ZHANG SPIERING, DONGXIU | 1 | 45.2% | +70.9% |
| NOTTINGHAM, KYLE GREGORY | 1 | 61.7% | +31.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916164 | PURE POLYURETHANE CONDOM HAVING ADHESIVE LAYER AND PREPARATION METHOD THEREFOR | LEE, MICHELLE J | 73d overdue |
| 17785959 | Personal Lubricant Composition | ZHANG SPIERING, DONGXIU | 12d |
| 18548645 | NOVEL COMPOSITION | GEMBEH, SHIRLEY V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916164 | PURE POLYURETHANE CONDOM HAVING ADHESIVE LAYER AND PREPARATION METHOD THEREFOR | LEE, MICHELLE J | 73d overdue |
| 18577534 | NOVEL USE OF POLYMER COMBINATION | ABBAS, ABDULRAHMAN MUSTAFA | 66d overdue |
| 18573628 | LAUNDRY SANITIZING COMPOSITION | ASDJODI, MOHAMMADREZA | 8d overdue |
| 17785959 | Personal Lubricant Composition | ZHANG SPIERING, DONGXIU | 12d |
| 18716337 | LAUNDRY SANITIZING AND SOFTENING COMPOSITION | ASDJODI, MOHAMMADREZA | 13d |
| 18851411 | LAMINATE HAVING IMPROVED TENSILE PROPERTIES | MELENDEZ, ARMAND | 49d |
| 18548645 | NOVEL COMPOSITION | GEMBEH, SHIRLEY V | — |
| 18245774 | AQUEOUS POLYURETHANE EMULSION, PREPARATION METHOD THEREFOR AND USE THEREOF | SERGENT, RABON A | — |
| Art Unit | Apps |
|---|---|
| 1767 | 2 |
| 1759 | 1 |
| 1612 | 1 |
| 1615 | 1 |
| 1765 | 1 |
| 1691 | 1 |
| 3786 | 1 |
| 1616 | 1 |
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18851411 | LAMINATE HAVING IMPROVED TENSILE PROPERTIES | MELENDEZ, ARMAND | 1759 | §103 | Non-Final OA | 49d | Pending | Sep 26, 2024 |
| 18716337 | LAUNDRY SANITIZING AND SOFTENING COMPOSITION | ASDJODI, MOHAMMADREZA | 1767 | §103 | Final Rejection | 13d | Pending | Jun 04, 2024 |
| 18577534 | NOVEL USE OF POLYMER COMBINATION | ABBAS, ABDULRAHMAN MUSTAFA | 1612 | §103DP | Final Rejection | 66d overdue | Pending | Jan 08, 2024 |
| 18573628 | LAUNDRY SANITIZING COMPOSITION | ASDJODI, MOHAMMADREZA | 1767 | §103 | Final Rejection | 8d overdue | Pending | Dec 22, 2023 |
| 18548645 | NOVEL COMPOSITION | GEMBEH, SHIRLEY V | 1615 | §102§103 | Final Rejection | — | Pending | Sep 01, 2023 |
| 18245774 | AQUEOUS POLYURETHANE EMULSION, PREPARATION METHOD THEREFOR AND USE THEREOF | SERGENT, RABON A | 1765 | §103 | Final Rejection | — | Pending | Mar 17, 2023 |
| 17999073 | IBUPROFEN CONTAINING SOFT GELATINE CAPSULE | LEE, ANDREW P | 1691 | §103 | Final Rejection | — | Pending | Nov 17, 2022 |
| 17916164 | PURE POLYURETHANE CONDOM HAVING ADHESIVE LAYER AND PREPARATION METHOD THEREFOR | LEE, MICHELLE J | 3786 | §103§112 | Final Rejection | 73d overdue | Pending | Sep 30, 2022 |
| 17785959 | Personal Lubricant Composition | ZHANG SPIERING, DONGXIU | 1616 | §103§112 | Non-Final OA | 12d | Pending | Jun 16, 2022 |
| 17429761 | COMPOSITIONS CONTAINING NSAIDS, SOLUBILISING AGENTS, AND THIXOTROPIC AGENTS AND METHODS OF PRODUCING AND USING SAME | NOTTINGHAM, KYLE GREGORY | 1621 | §103Other | Final Rejection | — | Pending | Aug 10, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial